Clinical Trials

Can AI Improve Diabetic Retinopathy and Macular Degeneration Screening?
Tech & Innovation Can AI Improve Diabetic Retinopathy and Macular Degeneration Screening?

Medical advancements are progressing rapidly, and one of the most promising areas is artificial intelligence (AI) in diagnostic imaging. AI technology has the potential to revolutionize healthcare by enhancing the accuracy and efficiency of diagnoses. Acer Medical recently introduced two

How Can Generative AI Revolutionize Clinical Trials?
Research & Development How Can Generative AI Revolutionize Clinical Trials?

Clinical trials have long been a cornerstone of medical research, essential for the development and approval of new drugs and treatments. However, they are often plagued by high costs, time constraints, and the complexities associated with patient recruitment. In recent years, the transformative

Harnessing Real-World Evidence to Streamline FDA Drug Approvals
Management & Regulatory Harnessing Real-World Evidence to Streamline FDA Drug Approvals

The article delves into the intriguing potential of real-world evidence (RWE) to revolutionize the U.S. Food and Drug Administration’s (FDA) approval process for new drugs. By relying more on real-world data (RWD), regulatory decisions could become quicker, more economical, and maintain the current

Can AI Chatbots Like Therabot Revolutionize Mental Health Treatment?
Tech & Innovation Can AI Chatbots Like Therabot Revolutionize Mental Health Treatment?

In an age where artificial intelligence continues to pervade every aspect of daily life, the idea of AI chatbots stepping into the realm of psychotherapy is no longer a far-fetched concept. Imagine reaching a point where a simple conversation with a machine could lessen the burden of your anxieties

Can Schrödinger’s AI Shift Transform Drug Discovery and Boost Growth?
Research & Development Can Schrödinger’s AI Shift Transform Drug Discovery and Boost Growth?

Schrödinger, a well-established player in the computational chemistry and drug discovery space, has recently made headlines by embracing artificial intelligence (AI). The company’s CEO, Ramy Farid, officially announced this strategic pivot during the presentation of the company's year-end results

Glucose Discovered as Key Regulator of Tissue Differentiation
Biotech & Bioprocessing Glucose Discovered as Key Regulator of Tissue Differentiation

Glucose, a simple sugar widely recognized for its role as the primary energy source for most living cells, has recently been discovered to play a critical role beyond its conventional function. In groundbreaking research conducted by a team at Stanford Medicine, glucose has been identified as a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later